Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | AMGN | GILD | CELG | ILMN |
| Company | Apellis Pharmaceuticals Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 47.32 | 310.88 | 64.78 | 108.01 | 118.04 |
| High | 49.06 | 312.73 | 65.56 | 108.59 | 119.39 |
| Low | 47.17 | 297.52 | 64.34 | 107.27 | 115.91 |
| Last | 48.81 | 299.48 | 65.54 | 108.24 | 118.98 |
| Change | +1.35 | -11.81 | +0.76 | +0.11 | +1.05 |
| % Change | +2.84% | -3.79% | +1.17% | +0.10% | +0.89% |
| Volume | 1,849,900 | 4,717,600 | 7,187,200 | 191,230,496 | 1,803,100 |
| 20-Day Average Volume | 1,652,525 | 2,791,225 | 7,536,365 | 16,188,930 | 1,504,875 |
| Previous Close | 47.46 | 311.29 | 64.78 | 108.13 | 117.93 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 49.59 | 273.78 | 66.69 | 108.17 | 122.90 |
| 20-Day Raw Stochastic | 53.95% | 62.66% | 21.53% | 63.25% | 16.64% |
| 20-Day Relative Strength | 42.90% | 62.69% | 34.71% | 64.69% | 41.59% |
| Weighted Alpha | -13.31 | +27.63 | -20.00 | +46.30 | -39.70 |
| Today's Opinion | 72% Sell | 24% Buy | 100% Sell | 100% Buy | 88% Sell |
| Previous Opinion | 72% Sell | 24% Buy | 100% Sell | 100% Buy | 88% Sell |
| Last Month's Opinion | 8% Buy | 8% Sell | 100% Sell | 100% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.03% since 04/29/24 | +8.36% since 04/29/24 | -0.61% since 04/29/24 | -1.97% since 11/13/19 | -4.61% since 04/29/24 |
| Low | 38.22 on 04/30/24 | 272.35 on 04/30/24 | 64.33 on 05/03/24 | 107.27 on 11/20/19 | 115.91 on 05/06/24 |
| High | 49.06 on 05/06/24 | 322.60 on 05/03/24 | 65.89 on 05/01/24 | 110.53 on 11/14/19 | 127.89 on 05/03/24 |
| 1-Month | |||||
| %Chg | -12.70% since 04/05/24 | +10.94% since 04/05/24 | -5.81% since 04/05/24 | +5.14% since 10/18/19 | -6.86% since 04/05/24 |
| Low | 38.22 on 04/30/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 102.40 on 10/21/19 | 115.73 on 04/18/24 |
| High | 57.85 on 04/11/24 | 322.60 on 05/03/24 | 69.95 on 04/09/24 | 110.70 on 11/13/19 | 135.26 on 04/09/24 |
| 3-Month | |||||
| %Chg | -27.48% since 02/06/24 | -5.25% since 02/06/24 | -15.67% since 02/06/24 | +13.63% since 08/20/19 | -17.88% since 02/06/24 |
| Low | 38.22 on 04/30/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 93.41 on 08/23/19 | 115.73 on 04/18/24 |
| High | 71.90 on 02/26/24 | 322.60 on 05/03/24 | 76.45 on 02/07/24 | 110.70 on 11/13/19 | 147.70 on 02/09/24 |
| 6-Month | |||||
| %Chg | +7.39% since 11/06/23 | +9.77% since 11/06/23 | -19.23% since 11/06/23 | +14.14% since 05/20/19 | +5.44% since 11/06/23 |
| Low | 38.22 on 04/30/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 89.08 on 07/23/19 | 89.00 on 11/10/23 |
| High | 73.80 on 01/09/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,756,613 | 166,968,480 | 80,656,088 | 77,035,920 | 18,780,942 |
| Shares Outstanding, K | 121,294 | 536,376 | 1,245,077 | 711,714 | 159,255 |
| Annual Sales | 396,590,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | -528,630,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 146,380,000 | 8,196,000,000 | 6,686,000,000 | 4,520,000,000 | 1,122,000,000 |
| Last Quarter Net Income | -88,580,000 | 767,000,000 | -4,170,000,000 | 1,691,000,000 | -176,000,000 |
| 60-Month Beta | 0.97 | 0.60 | 0.22 | 1.41 | 1.20 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 02/27/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 0.09 on 05/02/24 |
| Latest Earnings Date | 05/07/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.94 | 16.21 | 10.99 | 140.90 |